• Ellen Eaton, MD, is Assistant Professor in the UAB Division of Infectious Diseases, a 2017-2019 Fellow of the National Academy of Medicine, and a UAB PCOR K12 Scholar with an interest in HIV/STI health outcomes and policy. Her current research evaluates patient preferences related to HIV treatment options and the use of decision analyses to compare the effectiveness of HIV treatments and STI testing strategies. Dr. Eaton recently conducted a study looking at the budgetary impact of compliance with STI Screening Guidelines in Persons Living with HIV. This work was presented as an oral presentation at the 2016 annual ID week in New Orleans, LA and recently published in the Journal of Acquired Immune Deficiency Syndrome (JAIDS). Dr. Eaton is currently preparing a K23 submission to NIH.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Brief Report: Kidney Dysfunction Does Not Contribute Significantly to Antiretroviral Therapy Modification in Treatment-Naive PLWH Receiving Initial ARTJournal of Acquired Immune Deficiency Syndromes.  81. 2019
    2019 A 9-Point Risk Assessment for Patients Who Inject Drugs and Require Intravenous Antibiotics: Focusing Inpatient Resources on Patients at Greatest Risk of Ongoing Drug UseZeitschrift für Physik D Atoms, Molecules and Clusters.  68:1041-1043. 2019
    2019 Incidence and predictors of reinfection with trichomoniasis based on nucleic acid amplification testing results in HIV-infected patientsInternational Journal of STD and AIDS.  30:344-352. 2019
    2018 Do young black men who have sex with men in the deep south prefer traditional over alternative STI testing?PLoS ONE.  13. 2018
    2018 Psychosocial stressors and sexual health among Southern African American women who have sex with womenLGBT Health.  5:234-241. 2018
    2018 Reverse syphilis screening algorithm fails to demonstrate cost effectiveness in persons living with HIVInternational Journal of STD and AIDS.  29:563-567. 2018
    2018 Potential kidney toxicity from the antiviral drug tenofovir: New indications, new formulations, and a new prodrugJournal of Commodity Science and Technology.  27:102-112. 2018
    2018 Trends in antiretroviral therapy prescription, durability and modification: New drugs, more changes, but less failureScience.  32:347-355. 2018
    2018 Mental health service utilization is associated with retention in care among persons living with HIV at a university-affiliated HIV clinicBulletin of the American College of Surgeons.  15. 2018
    2018 Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015AIDS Patient Care and STDS.  23:363-372. 2018
    2017 Patient preferences for antiretroviral therapy: Effectiveness, quality of life, access and novel delivery methodsPatient Preference and Adherence.  11:1585-1590. 2017
    2017 Antiretroviral therapy initiation and changes in self-reported depressionZeitschrift für Physik D Atoms, Molecules and Clusters.  64:1791-1794. 2017
    2017 Budgetary impact of compliance with sti screening guidelines in persons living with HIVJournal of Acquired Immune Deficiency Syndromes and Human Retrovirology.  74:303-308. 2017
    2017 The relationship between efavirenz as initial antiretroviral therapy and suicidal thoughts among HIV-infected adults in routine careJournal of Acquired Immune Deficiency Syndromes and Human Retrovirology.  76:402-408. 2017
    2016 Editorial Commentary: Affordable Care Act, Medicaid Expansion ... or Not: Ryan White Care Act Remains Essential for Access and EquityZeitschrift für Physik D Atoms, Molecules and Clusters.  63:404-406. 2016
    2016 Unanticipated effects of new drug availability on antiretroviral durability: Implications for comparative effectiveness researchOpen Forum Infectious Diseases.  3. 2016
    2016 Cost considerations in the current antiretroviral eraScience.  30:2215-2219. 2016
    2015 Immunization costs and programmatic barriers at an urban HIV clinicZeitschrift für Physik D Atoms, Molecules and Clusters.  61:1726-1731. 2015
    2014 Barrier Methods for Human Immunodeficiency Virus PreventionInfectious Disease Clinics of North America.  28:585-599. 2014
    2014 Engagement in human immunodeficiency virus care: Linkage, retention, and antiretroviral therapy adherenceInfectious Disease Clinics of North America.  28:355-369. 2014
    2012 Profound neurotoxicity and treatment response following one cycle of bortezomib therapy in an elderly male with multiple myelomaJournal of Pharmacy Technology.  28:193-196. 2012
    2011 West Nile virus encephalitis acquired via liver transplantation and clinical response to intravenous immunoglobulin: Case report and review of the literatureTransplant Infectious Disease.  13:312-317. 2011

    Education And Training

  • Master of Public Health, University of Alabama at Birmingham 2017
  • Doctor of Medicine in Internal Medicine Residency Program, University of Alabama at Birmingham 2007
  • Bachelor's Degree in Chemistry, Vanderbilt University 2003
  • Stanford University Medical Center, Residency 2011
  • Stanford University Medical Center, Residency 2010
  • UAB, Postdoctoral Fellowship 2016
  • Full Name

  • Ellen Eaton